All

Results: 58573-58584 of 67588

PR Newswire associated0

FIRST PATIENTS ENROLLED IN THE GORE VBX FORWARD CLINICAL STUDY

PR Newswire associated0

Second Front Systems receives strategic investment from Booz Allen to rapidly scale emerging tech for national security

PR Newswire associated0

Unchained Labs has the inside track on Lentivirus RNA detection, launches new Leprechaun application!

PR Newswire associated0

Epitomee® Announces Successful Completion of Pivotal Clinical Trial for Innovative Weight Loss Capsule

GTT Expands Its SASE Portfolio With Fortinet to Offer Enterprises a Robust Suite of Security Solutions Uniquely Enabled by GTT’s Global Tier 1 IP Backbone

U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions

KAYAK reveals when to book flights for popular summer holidays

Single Use Support continues to grow, expanding its team by 40%

PR Newswire associated0

Innovative Data Center Solutions Provider Inova Announces Its Launch

On January 11th, trailblazing medical technology company Xenco Medical unveiled its convergent technology bridging Digital Health and Biomaterials by showcasing its TrabeculeX Continuum™ at the 2024 Consumer Electronics Show in Las Vegas, Nevada. Comprising the TrabeculeX Bioactive Matrix™ and the TrabeculeX Recovery App™, the TrabeculeX Continuum is the first technology-enabled bridge between orthobiologics and digital health, unifying a patient’s biomaterial implantation and postoperative journey. (Graphic: Business Wire)

Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials, at CES 2024 in Las Vegas, the World’s Largest Technology Conference

Morgan Stanley Fourth Quarter and Full Year 2023 Earnings Results